Make sterile connections faster, easier and safer with genderless connectors - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Make sterile connections faster, easier and safer with genderless connectors

Genderless AseptiQuik® G sterile connectors from CPC simplify single-use systems design and process integration. Our innovative design eliminates separate male and female components to substantially reduce complexity and support modular system design. Because the connectors are interchangeable—any single-use G series connector mates with any other G series connector—systems are more flexible and minimize supply chain complexity.

G series connectors are available in a full range of interchangeable 6.4 mm to 19.0 mm (1/4” to 3/4”) flow solutions, in both gamma and high-temperature versions. Terminations include 6.4 mm to 19.0 mm hose barb and 19.0 mm mini-sanitary.

The G series is part of the AseptiQuik family which offers the broadest range of single-use sterile connectors in the industry with flow configurations from 3.2 mm to 25.4 mm (1/8” to 1”). AseptiQuik connectors provide ease-of-use, robust construction and reliable performance for transferring valuable media. AseptiQuik’s are ideal for single-bag and tubing assemblies,cell banking, bioreactors, mixers,
sampling, formulation and filling applications.

See how the G series works AseptiQuik G video

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerRelationship-building at Top of Mind for Clients
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerRisk Reduction Top Driver for Biopharmaceutical Raw Material Development
Jill Wechsler Regulatory Watch Jill Wechsler Changes and Challenges for Generic Drugs
Faiz Kermaini Industry Insider Faiz KermainiNo Signs of a Slowdown in Mergers
From Generics to Supergenerics
CMOs and the Track-and-Trace Race: Are You Engaged Yet?
Ebola Outbreak Raises Ethical Issues
Better Comms Means a Fitter Future for Pharma, Part 2: Realizing the Benefits of Unified Communications
Better Comms Means a Fitter Future for Pharma, Part 1: Challenges and Changes
FindPharma Custom Search

Click here